Hoya Vision Care launch myopia consensus statement

Published on December 11, 2025
A panel of experts from epidemiology, policy, sustainability, clinical care, and patient advocacy called for a coordinated global strategy
Continue reading on website
Other news

Ortho-k: More than meets the eye to control myopia progression | Optometry Times - Clinical News

December 11, 2025
An effective but underused resource with positive benefits for patients with myopia.

ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA | Optometry Times - Clinical News

December 11, 2025
Xelafaslatide is a small-molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death.